MRS-7216

N/A

Report date: 2025/01/26 16:26:26
NME

Base Information

Drug NameMRS-7216
Drug Alias NameA2A adenosine receptor selective agonist (NIH/NYU Langone Health)alendronate CGS-21680 conjugate (NIH/NYU Langone Health)MRS-7216
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor agonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsOsteolysis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthNyu Langone Health
Inactive CompaniesN/A
Active IndicationsOsteolysis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A